# Minds AI Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/minds-ai-co

- Industry: Healthcare Specialists
- Headquarters: Seoul, South Korea
- Website: www.mindsai.co.kr/
- Total disclosed funding: $1.2M
- Latest round: Series A (May 7, 2024)
- Investors on record: 4

## About

Founded in 2019 and based in Seoul, South Korea, Minds AI Co., Ltd. operates as a healthcare company that develops a tool used to provide diagnostic analysis based on psychological and physical indexes. In May 2024, Minds AI raised KRW 1 billion in Series A funding led by Stonebridge Ventures and Yonsei Technology Holdings. As of 2024, the company is led by its CEO, Seok Jeong-ho.

The company specializes in mental health services, integrating biotechnology and artificial intelligence to offer mental health solutions. The firm’s offerings include the PROVE Test for depression and stress analysis using saliva hormone kits, VR-based emotional regulation programs, and professional psychological counseling. MindsAI improves mental health accessibility and reduces stigma by providing scientifically backed, user-friendly tools for mental wellness. The company collaborates with institutions like Gangnam Severance Hospital and the National Center for Mental Health to enhance their service reach and efficacy.

## Funding rounds

- Series A, May 7, 2024, $0.7M — Yonsei Technology Holdings, Stonebridge Ventures
- Seed, Sep 1, 2021, $0.4M — Bluepoint Partners, Korea Tech Incubator for Startup

## Investors

- Bluepoint Partners (https://capitalatlas.ai/funds/bluepoint-partners) — Seed
- Korea Tech Incubator for Startup — Seed
- Yonsei Technology Holdings (https://capitalatlas.ai/funds/yonsei-technology-holdings) — Series A
- Stonebridge Ventures — Series A